"The
Report Portal Hypertension - Pipeline Review, H1 2016 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
Global
Markets Directs, Portal
Hypertension - Pipeline Review, H1 2016,
provides an overview of the Portal Hypertension pipeline landscape.
The
report provides comprehensive information on the therapeutics under
development for Portal Hypertension, complete with analysis by stage
of development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for Portal Hypertension and features
dormant and discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Portal Hypertension
-
The report reviews pipeline therapeutics for Portal Hypertension by
companies and universities/research institutes based on information
derived from company and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved Portal Hypertension
therapeutics and enlists all their major and minor projects
-
The report assesses Portal Hypertension therapeutics based on drug
target, mechanism of action (MoA), route of administration (RoA) and
molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Portal Hypertension
Reasons to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Portal Hypertension
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Portal Hypertension pipeline depth and focus of Indication
therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Download Sample copy of this
Report at: http://www.marketresearchreports.biz/sample/sample/713871
Table Of Content
Table
of Contents 2
List
of Tables 4
List
of Figures 4
Introduction
5
Global
Markets Direct Report Coverage 5
Portal
Hypertension Overview 6
Therapeutics
Development 7
Pipeline
Products for Portal Hypertension - Overview 7
Portal
Hypertension - Therapeutics under Development by Companies 8
Portal
Hypertension - Pipeline Products Glance 9
Clinical
Stage Products 9
Early
Stage Products 10
Portal
Hypertension - Products under Development by Companies 11
Portal
Hypertension - Companies Involved in Therapeutics Development 12
Conatus
Pharmaceuticals Inc. 12
Galectin
Therapeutics, Inc. 13
Gilead
Sciences, Inc. 14
Intercept
Pharmaceuticals, Inc. 15
LinXis
B.V. 16
Mezzion
Pharma Co. Ltd. 17
Ono
Pharmaceutical Co., Ltd. 18
Portal
Hypertension - Therapeutics Assessment 19
Assessment
by Monotherapy Products 19
Assessment
by Target 20
Assessment
by Mechanism of Action 22
Assessment
by Route of Administration 24
Assessment
by Molecule Type 26
Drug
Profiles 28
emricasan
- Drug Profile 28
Product
Description 28
Mechanism
of Action 28
R&D
Progress 28
Browse Our Press Releases by
Prnewswire:
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment